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be used before more extensive investigations of patients
with unexplained hypoalbuminemia and edema.6–9
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The utility of multivariate analysis
in the study of hepcidin
Kidney International (2009) 76, 912; doi:10.1038/ki.2009.272
To the Editor: In their recent publication, Ashby et al.1
examined serum hepcidin levels in chronic kidney disease
(CKD) using a novel immunoassay. Although they found
a positive correlation between hepcidin and ferritin in
non-dialysis CKD patients, they did not identify a correlation
in patients on hemodialysis with univariate analysis. This
was attributed to a lack of variation in ferritin levels, which
were high because of ‘target-driven treatment with
intravenous iron’.
However, in Table 1 they present a multivariate model
adjusted for erythropoietin and hemoglobin, which shows
a correlation between hepcidin and ferritin (b¼ 0.247,
P¼ 0.013) in the hemodialysis group. Similarly, the authors
state that no relationship was seen between hepcidin and
interleukin-6 levels, but the same multivariate model shows a
correlation between the two variables (b¼ 0.195, P¼ 0.054).
These correlations seen in the multivariate model by
Ashby et al. are in line with previous results indicating that
hepcidin production is increased by iron loading and
inflammation.2 Since their publication, using another
immunoassay, we have found with multivariate analysis a
positive correlation between hepcidin and both high-
sensitivity C-reactive protein and ferritin in pediatric and
adult CKD patients.3 Thus, given its complex regulation,
multivariate analysis may be necessary when attempting to
examine relationships between hepcidin and markers of iron
status, inflammation and erythropoiesis.
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Multiple linear regression (MLR) is a useful technique
for examining the manner in which a set of explanatory
variables account for differences in hepcidin levels within a
group. Zairitsky and Young1 point out that significant partial
correlations emerged in our MLR model for predictors that
were not associated with hepcidin in bivariate analyses, and
suggest that our underinterpretation is due to insufficient
reliance on MLR.
Figure 4 of our report demonstrates clearly the influence
of ferritin and iron loading on hepcidin in renal failure and
dialysis patients, and indicates the ferritin clustering (due
to the regular use of intravenous iron to ensure a minimum
ferritin of 400 ng/ml), which explains the poor correlation
within the dialysis group.2 The MLR model adjusted for
hemoglobin and erythropoietin does hint at other possible
influences, but these were not incorporated into the model,
as several mutually redundant predictors were present, and
further inclusion produced little overall improvement in
the model. For both ferritin and interleukin-6, it is clear
that lack of influence within the group in no way implies
lack of effect on the group.
MLR has significant drawbacks, being highly dependent
on the set of explanatory variables available and the
simultaneous interpretation of multiple P-values. Over-
reliance, particularly when the ratio of observations to
predictors is low, may lead to spurious associations while
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still missing real ones. MLR is necessary, but, as in our
report, should be interpreted conservatively, alongside other
forms of reasoning.
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Overexpression of cytochrome
P450 4F2 in mice increases
20-hydroxyeicosatetraenoic
acid production and arterial
blood pressure
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To the Editor: Liu et al. constructed a transgenic mouse
(TM) model overexpressing CYP4F2.1 They found enhanced
20-hydroxyeicosatetraenoic acid (HETE) production and
elevated blood pressure in TM and a positive correlation of
blood pressure with urinary 20-HETE levels, suggesting that
these findings are directly transferable to humans. We feel
that this passage is not so straightforward. 20-HETE has both
pro- and antihypertensive properties, depending on the site
of action: vasculature vs kidney tubuli, a finding that marks
the difference also in animal models, in which 20-HETE is
either prohypertensive (spontaneously hypertensive rats) or
antihypertensive (Dahl salt-sensitive rats). In humans,
CYP4F2 has maximal expression at the renal tubular level,
suggesting a major action of CYP4F2 as a natriuretic
substance. Other studies, in which 20-HETE was measured
using gas chromatography–mass spectrometry techniques,
showed a prevalently antihypertensive role of human 20-
HETE: Laffer2 found that the altered response of 20-HETE is
associated with salt-sensitive hypertension, and our group3
found decreased levels of urinary 20-HETE in patients with
hypertension compared with matched controls.
Moreover, V433M polymorphism, which was cited by the
authors in support of their hypothesis, decreases the activity
of the enzyme in vitro,4 suggesting that a prohypertensive
action can be hypothesized only if it acts at tubular level.
Indeed, this variant was associated with prevalence of hyper-
tension and incidence of stroke in a large population,5 even
though this was found only in males, suggesting a possible
role of testosterone in its regulation, as indicated also by Liu.
Therefore, extrapolation of the findings from the TM model
to humans should be done cautiously. Nevertheless, these
results encourage active research on the effect of eicosanoids
derived by CYP450 in hypertension.
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Our colleagues recently established a novel CYP4F2
transgenic (TG) mouse model that showed increased
20-hydroxyeicosatetraenoic acid (HETE) production and
elevated blood pressure.1 We are thankful to Dr Fava for
his interest and opinion.2 20-HETE, a vasoconstrictor and
a sodium-reabsorption inhibitor, has both prohypertensive
and antihypertensive properties. Reports on the role of
20-HETE in blood pressure regulation remained diverse
both in population association studies, with positive
correlation in some studies3,4 but not in others, and in
rodent models, with a prohypertensive effect in sponta-
neously hypertensive rats but antihypertensive action in
Dahl salt-sensitive rats. These discrepancies indeed
prompted us to construct a CYP4F2 TG model to evaluate
the overall effect of 20-HETE in vivo.
TG mice expressing CYP4F2 at renal tubules and other
extrarenal tissues developed hypertension on increased
20-HETE production, suggesting that a prohypertensive
role of 20-HETE was dominant. As for the antihypertensive
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